International Stem Cell Corporation (ISCO)
|Net Income (ttm)||-4.72M|
|Trading Day||February 26|
|Day's Range||0.8899 - 0.9299|
|52-Week Range||0.3 - 1.08|
There are no news available yet.
International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes. The company also develops, manufactures, and markets skincare... [Read more...]
Dr. Andrey Semechkin
|Stock Exchange |
|Ticker Symbol |
In 2019, ISCO's revenue was $9.47 million, a decrease of -14.58% compared to the previous year's $11.09 million. Losses were -$4.27 million, 100.1% more than in 2018.
The average 12-month stock price forecast for ISCO is 0.54, which is a decrease of -41.93% from the latest price.